Allergy Therapeutics PLC

NEW
LSE:AGY (UK)  
£ 0.055 +0.0025 (+4.76%) Aug 7
At Loss
P/B:
53.93
Market Cap:
£ 348.29M ($ 469.88M)
Enterprise V:
£ 364.96M ($ 492.36M)
Volume:
121.75K
Avg Vol (2M):
251.39K
Trade In:
Volume:
121.75K
At Loss
Avg Vol (2M):
251.39K

Allergy Therapeutics PLC (LSE:AGY) Dividend

Allergy Therapeutics PLC (LSE:AGY) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -94.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LSE:AGY Dividend

Does Allergy Therapeutics PLC (LSE:AGY) pay a dividend?

Allergy Therapeutics PLC (LSE:AGY) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Allergy Therapeutics PLC pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Allergy Therapeutics PLC has returned capital to shareholders via buybacks at a rate of -94.9% over the past 3 years.

What are dividend-paying alternatives to Allergy Therapeutics PLC?

For dividend-paying alternatives in Allergy Therapeutics PLC's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.